GSTM1 and anemia (phenotype): Hence the positive correlation of arsenic with the anemia end-points (prior month ESA dose, Hb concentration, and ER) may reflect both the combined effects of sub-toxic levels of arsenic and increased erythroid colony formation with increased need for ESA dosing to achieve Hb target levels.